PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2017.002132017352144-152Radiation for persistent or recurrent epithelial ovarian cancer: a need for reassessmentNoorie Choi, Ji Hyun Chang, Suzy Kim, Hak Jae Kimhttp://e-roj.org/upload/pdf/roj-2017-00213.pdf, http://e-roj.org/journal/view.php?doi=10.3857/roj.2017.00213, http://www.e-roj.org/upload/pdf/roj-2017-00213.pdf
Ovarian Cancer - From Pathogenesis to Treatment10.5772/intechopen.808902018Chemotherapy for Primary and Recurrent Epithelial Ovarian CancerNora Naqoshttp://www.intechopen.com/download/pdf/63466
Clinical Trials in Ovarian Cancer10.36019/9780813586496-0072019200-2625. Recurrent Epithelial Ovarian Cancerhttps://www.degruyter.com/view/book/9780813586496/10.36019/9780813586496-007.xml, https://www.degruyter.com/document/doi/10.36019/9780813586496-007/xml, https://www.degruyter.com/document/doi/10.36019/9780813586496-007/pdf
Oncology10.1159/0001085912006715-6309-311Optimizing Management of Recurrent Epithelial Ovarian Cancer: A Critical Need for Evidence-Based DataMaurie Markmanhttps://www.karger.com/Article/Pdf/108591, https://www.karger.com/Article/Pdf/108591
Advances in Radiation Oncology10.1016/j.adro.2020.11.009202161100624Palliative Radiation Therapy for Metastatic, Persistent, or Recurrent Epithelial Ovarian Cancer: Efficacy in the Era of Modern Technology and Targeted AgentsAnish A. Butala, Roshal R. Patel, Shwetha Manjunath, Nawar A. Latif, Ashley F. Haggerty, Joshua A. Jones, Neil K. Taunkhttps://api.elsevier.com/content/article/PII:S2452109420303547?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2452109420303547?httpAccept=text/plain
Gynecologic Oncology10.1016/0090-8258(86)90256-81986232253-254Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancerD.S. Miller, S.C. Ballon, O.M. Soriero, N.N.H. Teng, D.B. Seiferhttps://api.elsevier.com/content/article/PII:0090825886902568?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0090825886902568?httpAccept=text/plain
International Journal of Radiation Oncology*Biology*Physics10.1016/0360-3016(84)90777-6198410139Advanced epithelial ovarian cancer: Preliminary results of whole abdominal irradiation for patients with recurrent or persistent disease after chemotherapyM. Schray, A. Martinez, A. Howes, S. Ballon, K. Podratz, G. Malkasian, B. Sikichttps://api.elsevier.com/content/article/PII:0360301684907776?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0360301684907776?httpAccept=text/plain
Gynecologic Oncology10.1016/j.ygyno.2019.04.5462019154235-236Efficacy of second line chemotherapeutic regimens in persistent or recurrent epithelial ovarian cancer including fallopian tube cancer and primary peritoneal cancer: A multicenter retrospective studyH.P. Lee, Y.B. Kimhttps://api.elsevier.com/content/article/PII:S0090825819310443?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825819310443?httpAccept=text/plain
Gynecologic Oncology10.1016/0090-8258(89)90903-71989321104-105Critical reassessment of “second-look” laparotomy in epithelial ovarian carcinoma. IV. Prognostic factors and treatment outcome in patients with persistent cancerD.S. Miller, N.M. Spirtos, S.C. Ballon, N.N.H. Teng, C.M. Sorierohttps://api.elsevier.com/content/article/PII:0090825889909037?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0090825889909037?httpAccept=text/plain
Cancer10.1002/1097-0142(19920115)69:2<502::aid-cncr2820690238>3.0.co;2-41992692502-510Critical reassessment of second-look exploratory laparotomy for epithelial ovarian carcinoma. Minimal diagnostic and therapeutic value in patients with persistent cancerDavid Scott Miller, Nick M. Spirtos, Samuel C. Ballon, Richard S. Cox, Olive M. Soriero, Nelson N. H. Tenghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19920115)69:2%3C502::AID-CNCR2820690238%3E3.0.CO;2-4, https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19920115)69:2%3C502::AID-CNCR2820690238%3E3.0.CO;2-4